In the fast-paced world of in vitro diagnostics (IVD), antibodies are the cornerstone of reliable diagnostic tests, powering everything from ELISA to lateral flow assays and multiplex immunoassays. Developing high-performance antibody pairs—crucial for accurate diagnostics—has traditionally been a slow, labor-intensive, and costly process. Enter artificial intelligence (AI), which is transforming this landscape by accelerating and refining the discovery, optimization, and validation of IVD antibody pairs. Here's how AI is reshaping the future of diagnostics.